Fusion Complexes and CD4-independent gp120s for the Induction of HIV-1 Neutralizing Antibodies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1742-4690

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Fusion Complexes and CD4-independent gp120s for the Induction of HIV-1 Neutralizing Antibodies ; volume:2 ; number:1 ; day:8 ; month:12 ; year:2005 ; pages:1 ; date:12.2005
Retrovirology ; 2, Heft 1 (8.12.2005), 1, 12.2005

Creator: Zipeto, D.

Contributor: Matucci, A.
Rossolillo, P.
Ripamonti, C.
Scarlatti, G.
Lopalco, L.
Hazan, U.
Bertazzoni, U.
SpringerLink (Online service)

DOI: 10.1186/1742-4690-2-S1-S121

URN: urn:nbn:de:1111-2016080651956

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Zipeto, D.
Matucci, A.
Rossolillo, P.
Ripamonti, C.
Scarlatti, G.
Lopalco, L.
Hazan, U.
Bertazzoni, U.
SpringerLink (Online service)

Other Objects (12)

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope

Broadly Neutralizing Antibodies for HIV Eradication

Egr2-independent, Klf1-mediated induction of PD-L1 in CD4+ T cells

Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine

Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate

Non-neutralizing antibodies and vaccine-induced protection

Eliciting neutralizing antibodies with gp120 outer domain

Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

P03-10. Induction of neutralizing antibodies in Rhesus macaques following mucosal challenge with R5 tropic SHIV162P3 isolate

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope

Broadly Neutralizing Antibodies for HIV Eradication

Egr2-independent, Klf1-mediated induction of PD-L1 in CD4+ T cells

Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine

Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate

Non-neutralizing antibodies and vaccine-induced protection

Eliciting neutralizing antibodies with gp120 outer domain

Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

P03-10. Induction of neutralizing antibodies in Rhesus macaques following mucosal challenge with R5 tropic SHIV162P3 isolate

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope

Broadly Neutralizing Antibodies for HIV Eradication

Egr2-independent, Klf1-mediated induction of PD-L1 in CD4+ T cells

Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine

Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate

Non-neutralizing antibodies and vaccine-induced protection

Eliciting neutralizing antibodies with gp120 outer domain

Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

P03-10. Induction of neutralizing antibodies in Rhesus macaques following mucosal challenge with R5 tropic SHIV162P3 isolate

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Fusion Complexes and CD4-independent gp120s for the Induction of HIV-1 Neutralizing Antibodies

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope

Broadly Neutralizing Antibodies for HIV Eradication

Egr2-independent, Klf1-mediated induction of PD-L1 in CD4+ T cells

Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine

Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate

Non-neutralizing antibodies and vaccine-induced protection

Eliciting neutralizing antibodies with gp120 outer domain

Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

P03-10. Induction of neutralizing antibodies in Rhesus macaques following mucosal challenge with R5 tropic SHIV162P3 isolate

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope

Broadly Neutralizing Antibodies for HIV Eradication

Egr2-independent, Klf1-mediated induction of PD-L1 in CD4+ T cells

Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine

Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate

Non-neutralizing antibodies and vaccine-induced protection

Eliciting neutralizing antibodies with gp120 outer domain

Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

P03-10. Induction of neutralizing antibodies in Rhesus macaques following mucosal challenge with R5 tropic SHIV162P3 isolate

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope

Broadly Neutralizing Antibodies for HIV Eradication

Egr2-independent, Klf1-mediated induction of PD-L1 in CD4+ T cells

Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine

Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate

Non-neutralizing antibodies and vaccine-induced protection

Eliciting neutralizing antibodies with gp120 outer domain

Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

P03-10. Induction of neutralizing antibodies in Rhesus macaques following mucosal challenge with R5 tropic SHIV162P3 isolate

The expanding array of HIV broadly neutralizing antibodies

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies

Related objects

Reset password